What to Expect When Starting an Oral GLP-1 for Obesity G lucagon-like peptide-1 receptor agonists, more commonly known as GLP-1s, have become popular treatments for obesity in recent years
Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats
Foundayo is a small molecule whereas Zepbound and Wegovy are peptides, which require more intensive manufacturing processes, a barrier Ricks thinks will hinder generic versions of Wegovy that have recently launched in some other countries, including India
Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R, et al
Importantly, targeting of MK-801 to GLP-1 receptor-expressing brain regions circumvents adverse physiological and behavioural effects associated with MK-801 monotherapy
Out of 6,576 case-patients in one surveillance study, five developed Clostridium butyricum bacteremia, and most of these patients were immunocompromised